Compile Data Set for Download or QSAR
Report error Found 353 of affinity data for UniProtKB/TrEMBL: D3DRH4
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658511BDBM50658511(CHEMBL6152639)
Ligand Info
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50539801BDBM50539801(CHEMBL4648912 | US11840533, Compound 70)
Affinity DataKd: <1nMAssay Description:Binding affinity to human partial length SMARCA2 (S1377 to Q1486 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50642737BDBM50642737(CHEMBL5564941)
Affinity DataIC50: 1.20nMAssay Description:Binding affinity to his-tagged BRM bromodomain (unknown origin) by alpha-LISA assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50661194BDBM50661194(CHEMBL6162306)
Affinity DataIC50: 1.60nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 394434BDBM394434(US10308614, Example 35 | 2-(6-amino-5-(pyrrolidin-)
Affinity DataKd:  2nMAssay Description:Binding affinity to SMARCA2 (unknown origin) assessed as dissociation constant by BROMOscan LeadHunter assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50661198BDBM50661198(CHEMBL6163796)
Affinity DataIC50: 2.30nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50642738BDBM50642738(CHEMBL5571722)
Affinity DataIC50: 2.70nMAssay Description:Binding affinity to his-tagged BRM bromodomain (unknown origin) by alpha-LISA assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658055BDBM50658055(CHEMBL6162599)
Affinity DataIC50: 2.80nMMore data for this Ligand-Target Pair
Ligand InfoPDB
In Depth
Date in BDB:
6/5/2026
Entry Details PubMedPDB3D3D Structure (crystal)
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658488BDBM50658488(CHEMBL6133855)
Ligand Info
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50628856BDBM50628856(CHEMBL5412292)
Affinity DataKd:  3nMAssay Description:Binding affinity to SMARCA2 (unknown origin) assessed as dissociation constant by BROMOscan LeadHunter assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658511BDBM50658511(CHEMBL6152639)
Ligand Info
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50661196BDBM50661196(CHEMBL6160404)
Affinity DataIC50: 3.60nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658486BDBM50658486(CHEMBL6145659)
Ligand Info
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658485BDBM50658485(CHEMBL6164767)
Ligand Info
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658484BDBM50658484(CHEMBL6166760)
Ligand Info
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658049BDBM50658049(CHEMBL6162246)
Affinity DataIC50: 4.60nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
LigandChemical structure of BindingDB Monomer ID 50469331BDBM50469331(CHEMBL4282980 | US11958846, Example 6)
Affinity DataIC50: 5nMAssay Description:All subsequent reagent additions were performed using a MultiFlo FX Multi-Mode Dispenser. Assay buffer was 20 mM HEPES pH 7.5, 1 mM MgCl2, 20 mM KCl,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2024
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 50469330BDBM50469330(CHEMBL4295096 | US11958846, Example 7)
Affinity DataIC50: 5nMAssay Description:All subsequent reagent additions were performed using a MultiFlo FX Multi-Mode Dispenser. Assay buffer was 20 mM HEPES pH 7.5, 1 mM MgCl2, 20 mM KCl,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2024
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 50469324BDBM50469324(CHEMBL4286345 | US11958846, Example 4)
Affinity DataIC50: 5nMAssay Description:All subsequent reagent additions were performed using a MultiFlo FX Multi-Mode Dispenser. Assay buffer was 20 mM HEPES pH 7.5, 1 mM MgCl2, 20 mM KCl,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2024
Entry Details
US Patent

TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50469330BDBM50469330(CHEMBL4295096 | US11958846, Example 7)
Affinity DataIC50: 5nMAssay Description:Inhibition of recombinant His10-tagged ZZ-HCV3C-BRM ATPase-SnAC (636 to 1331 residues) (unknown origin) expressed in insect sf9 cells preincubated fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2020
Entry Details Article
PubMed
LigandChemical structure of BindingDB Monomer ID 50469320BDBM50469320(CHEMBL4293567 | US11958846, Example 5)
Affinity DataIC50: 5nMAssay Description:All subsequent reagent additions were performed using a MultiFlo FX Multi-Mode Dispenser. Assay buffer was 20 mM HEPES pH 7.5, 1 mM MgCl2, 20 mM KCl,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2024
Entry Details
US Patent

TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50469329BDBM50469329(CHEMBL4278436 | US11958846, Example 1)
Affinity DataIC50: 5nMAssay Description:Inhibition of recombinant His10-tagged ZZ-HCV3C-BRM ATPase-SnAC (636 to 1331 residues) (unknown origin) expressed in insect sf9 cells preincubated fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2020
Entry Details Article
PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50469331BDBM50469331(CHEMBL4282980 | US11958846, Example 6)
Affinity DataIC50: 5nMAssay Description:Inhibition of recombinant His10-tagged ZZ-HCV3C-BRM ATPase-SnAC (636 to 1331 residues) (unknown origin) expressed in insect sf9 cells preincubated fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2020
Entry Details Article
PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658478BDBM50658478(Camibirstat | Fhd-286)
Ligand Info
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658510BDBM50658510(CHEMBL6141585)
Ligand Info
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658478BDBM50658478(Camibirstat | Fhd-286)
Ligand Info
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50469320BDBM50469320(CHEMBL4293567 | US11958846, Example 5)
Affinity DataIC50: 5nMAssay Description:Inhibition of recombinant His10-tagged ZZ-HCV3C-BRM ATPase-SnAC (636 to 1331 residues) (unknown origin) expressed in insect sf9 cells preincubated fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2020
Entry Details Article
PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658516BDBM50658516(CHEMBL6162637)
Ligand Info
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50469324BDBM50469324(CHEMBL4286345 | US11958846, Example 4)
Affinity DataIC50: 5nMAssay Description:Inhibition of recombinant His10-tagged ZZ-HCV3C-BRM ATPase-SnAC (636 to 1331 residues) (unknown origin) expressed in insect sf9 cells preincubated fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2020
Entry Details Article
PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50469330BDBM50469330(CHEMBL4295096 | US11958846, Example 7)
In Depth
Date in BDB:
6/6/2026
Entry Details PubMed
LigandChemical structure of BindingDB Monomer ID 50469329BDBM50469329(CHEMBL4278436 | US11958846, Example 1)
Affinity DataIC50: 5nMAssay Description:All subsequent reagent additions were performed using a MultiFlo FX Multi-Mode Dispenser. Assay buffer was 20 mM HEPES pH 7.5, 1 mM MgCl2, 20 mM KCl,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2024
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 394585BDBM394585(US10308614, Example 188 | 2-(6-amino-5-(1-(1-)
Affinity DataIC50: 5.70nMAssay Description:Histidine epitope tagged BRM (Isoform 2) Bromodomain1377-1486 (S1377-Q1486; Swiss Prot P51531-2; mhhhhhhgslvprgsSPNPPKLTKQMNAIIDTVINYKDSSGRQLSEVFIQLP...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658504BDBM50658504(CHEMBL6162908)
Ligand Info
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658520BDBM50658520(CHEMBL6167580)
Ligand Info
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658517BDBM50658517(CHEMBL6144331)
Ligand Info
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658520BDBM50658520(CHEMBL6167580)
Ligand Info
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50661199BDBM50661199(CHEMBL6134086)
Affinity DataIC50: 6.30nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50661195BDBM50661195(CHEMBL6165182)
Affinity DataIC50: 6.70nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658510BDBM50658510(CHEMBL6141585)
Ligand Info
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658526BDBM50658526(CHEMBL6133150)
Ligand Info
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
LigandChemical structure of BindingDB Monomer ID 394575BDBM394575(US10308614, Example 178 | 2-(6-amino-5-(2-)
Affinity DataIC50: 7.20nMAssay Description:Histidine epitope tagged BRM (Isoform 2) Bromodomain1377-1486 (S1377-Q1486; Swiss Prot P51531-2; mhhhhhhgslvprgsSPNPPKLTKQMNAIIDTVINYKDSSGRQLSEVFIQLP...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658523BDBM50658523(CHEMBL6143779)
Ligand Info
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658517BDBM50658517(CHEMBL6144331)
Ligand Info
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50661197BDBM50661197(CHEMBL6168928)
Affinity DataIC50: 8.10nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658050BDBM50658050(CHEMBL6102929)
Affinity DataIC50: 8.80nMMore data for this Ligand-Target Pair
Ligand InfoPDB
In Depth
Date in BDB:
6/5/2026
Entry Details PubMedPDB3D3D Structure (crystal)
LigandChemical structure of BindingDB Monomer ID 394605BDBM394605(US10308614, Example 209 | 2-(6-amino-5-cyclohexylp...)
Affinity DataIC50: 8.80nMAssay Description:Histidine epitope tagged BRM (Isoform 2) Bromodomain1377-1486 (S1377-Q1486; Swiss Prot P51531-2; mhhhhhhgslvprgsSPNPPKLTKQMNAIIDTVINYKDSSGRQLSEVFIQLP...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50664993BDBM50664993(CHEMBL6174634)
Ligand Info
In Depth
Date in BDB:
6/6/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658526BDBM50658526(CHEMBL6133150)
Ligand Info
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50658500BDBM50658500(CHEMBL6150430)
Ligand Info
In Depth
Date in BDB:
6/5/2026
Entry Details PubMed
TargetProbable global transcription activator SNF2L2(Human)
Foghorn Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50664992BDBM50664992(CHEMBL6175093)
Affinity DataIC50: 9.10nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/6/2026
Entry Details PubMed
Displayed 1 to 50 (of 353 total ) | Next | Last >>
Jump to: